China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes

31 Luglio 2020

Chinese companies are at the forefront of global efforts to create a vaccine for the coronavirus, with more than half a dozen candidates in clinical development. Last week, Tianjin-based CanSino Biologics published results1 from an early-stage clinical trial showing that its vaccine is safe and can trigger an immune response.


Prosegui la lettura su Nature

Avviso sui cookie di WordPress da parte di Real Cookie Banner